Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266669 · ClinicalTrials.gov registry record · Phase 3
Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon
A Phase 3 study, sponsored by MediQuest Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
NCT00266669: Completed Phase 3 study, sponsored by MediQuest Therapeutics.
NCT00266669 is a Phase 3 study that has completed, run by MediQuest Therapeutics. The registered enrollment target is 200 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00266669, a Phase 3 study, has completed, sponsored by MediQuest Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the efficacy and safety of a topical gel formulation of nitroglycerin, in comparison to a matching placebo, for patients with moderate to severe primary Raynaud's phenomenon or patients with Raynaud's phenomenon secondary to autoimmune diseases, such as scleroderma.
Interventions
- DRUG Topical organogel with nitroglycerin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2005-12 |
| Est. Completion | 2006-05 |
| Phase | Phase 3 |
What the finished NCT00266669 record still lists
NCT00266669 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Topical organogel with nitroglycerin is the first listed.
NCT00266669 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00266669 about?
NCT00266669 is a clinical study titled "Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon". The purpose of this study is to investigate the efficacy and safety of a topical gel formulation of nitroglycerin, in comparison to a matching placebo, for patients with moderate to severe primary Raynaud's phenomenon or patients with Raynaud's phenomenon secondary to autoimmune diseases, such as sc...
What is the current status of trial NCT00266669?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2005-12. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00266669?
The interventions under investigation include: Topical organogel with nitroglycerin (DRUG).
Who is sponsoring clinical trial NCT00266669?
This trial is sponsored by MediQuest Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00266669's enrollment target sits among peer trials
200 1353rd of 2000 higher than 613 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia